N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma

Neoplasia (United States)

Volumn 15, Issue 12, 2013, Pages 1363-1370

  Armstrong, Michael B ^a   Mody, Rajen J ^b   Christian Ellis, D ^a   Hill, Adam B ^a   Erichsen, David A ^b   Wechsler, Daniel S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MXI1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MXI1 0 GENE; MXI1 GENE; NEUROBLASTOMA; ONCOGENE C MYB; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 84891615369     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11606     Document Type: Article

References (48)

1. Maris JM, Hogarty MD, Bagatell R, and Cohn SL (2007). Neuroblastoma. Lancet 369, 2106-2120.
2. Cheung NK and Dyer MA (2013). Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 13, 397-411.
3. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, and Hammond D (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313, 1111-1116.
4. Maris JM and Matthay KK (1999). Molecular biology of neuroblastoma. J Clin Oncol 17, 2264.
5. Brodeur GM (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3, 203-216.
6. Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, et al. (2011). Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 261, 243-257.
7. Schwab M, Varmus HE, and Bishop JM (1985). Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316, 160-162.
8. Small MB, Hay N, Schwab M, and Bishop JM (1987). Neoplastic transformation by the human gene N-myc. Mol Cell Biol 7, 1638-1645.
9. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, and Bishop JM (1997). Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 16, 2985-2995.
10. Ayer DE, Kretzner L, and Eisenman RN (1993). Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222.
11. Hurlin PJ, Queva C, and Eisenman RN (1997). Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 11, 44-58.
12. Hurlin PJ, Quéva C, Koskinen PJ, Steingrímsson E, Ayer DE, Copeland NG, Jenkins NA, and Eisenman RN (1995). Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 14, 5646-5659.
13. Zervos AS, Gyuris J, and Brent R (1993). Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232.
14. Alland L, Muhle R, Hou H Jr, Potes J, Chin L, Schreiber-Agus N, and DePinho RA (1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55.
15. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, et al. (1997). A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48.
16. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, and Eisenman RN (1997). Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356.
17. Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, and Lüscher B (1997). Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol 7, 357-365.
18. Cascón A and Robledo M (2012). MAX and MYC: a heritable breakup. Cancer Res 72, 3119-3124.
19. O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelman JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, et al. (2000). Gene-target recognition among members of the Myc superfamily and implications for oncogenesis. Nat Genet 24, 113-119.
20. Corn PG, Ricci MS, Scata KA, Arsham AM, Simon MC, Dicker DT, El-Deiry WS, Corn PG, Ricci MS, Scata KA, et al. (2005). Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther 4, 1285-1294.
21. Löfstedt T, Fredlund E, Noguera R, Navarro S, Holmquist-Mengelbier L, Beckman S, Påhlman S, and Axelson H (2009). HIF-1α induces MXI1 by alternate promoter usage in human neuroblastoma cells. Exp Cell Res 315, 1924-1936.
22. Mohlin S, Hamidian A, and Pahlman S (2013). HIF2A and IGF2 expression correlates in human neuroblastoma cells and normal immature sympathetic neuroblasts. Neoplasia 15, 328-334.
23. Wong WJ and Simon MC (2008). The role of MXI1 in VHL deficient tumorigenesis. Cancer Biol Ther 7, 1628-1629.
24. Zhang L, Flygare J, Wong P, Lim B, and Lodish HF (2011). miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1. Genes Dev 25, 119-124.
25. Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K, Xu H, and Jiang S (2013). miR- 24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol 42, 757-766.
26. Lee TC and Ziff EB (1999). Mxi1 is a repressor of the c-myc promoter and reverses activation by USF. J Biol Chem 274, 595-606.
27. Wechsler DS, Shelly CA, Petroff CA, and Dang CV (1997). MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res 57, 4905-4912.
28. Engstrom LD, Youkilis AS, Gorelick JL, Zheng D, Ackley V, Petroff CA, Benson LQ, Coon MR, Zhu X, Hanash SM, et al. (2004). Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas. Neoplasia 6, 660-673.
29. Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A, and Lisanti MP (2001). Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry 40, 3354-3362.
30. Li LH, Nerlov C, Prendergast G, MacGregor D, and Ziff EB (1994). c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J 13, 4070-4079.
31. Brodeur GM, Seeger RC, Schwab M, Varmus HE, and Bishop JM (1985). Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage. Prog Clin Biol Res 175, 105-113.
32. Stigliani S, Coco S, Moretti S, Oberthuer A, Fischer M, Theissen J, Gallo F, Garavent A, Berthold F, Bonassi S, et al. (2012). High genomic instability predicts survival in metastatic high-risk neuroblastoma. Neoplasia 14, 823-832.
33. Amati B and Land H (1994). Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 4, 102-108.
34. Amati B, Alevizopoulos K, and Vlach J (1998). Myc and the cell cycle. Front Biosci 3, d250-d268.
35. Prins J, De Vries EG, and Mulder NH (1993). The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types. Anticancer Res 13, 1373-1385.
36. Schmidt ML, Salwen HR, Manohar CF, Ikegaki N, and Cohn SL (1994). The biological effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ 5, 171-178.
37. Guo XL, Pan L, Zhang XJ, Suo XH, Niu ZY, Zhang JY, Wang F, Dong ZR, Da W, and Ohno R (2007). Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia. Leuk Lymphoma 48, 1200-1207.
38. Taj MM, Tawil RJ, Engstrom LD, Zeng Z, Hwang C, Sanda MG, and Wechsler DS (2001). Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells. Prostate 47, 194-204.
39. Schreiber-Agus N, Meng Y, Hoang T, Hou H Jr, Chen K, Greenberg R, Cordon- Cardo C, Lee HW, and DePinho RA (1998). Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393, 483-487.
40. Yoo KH, Sung YH, Yang MH, Jeon JO, Yook YJ, Woo YM, Lee HW, and Park JH (2007). Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney. Biochem Biophys Res Commun 356, 85-90.
41. Yoo KH, Kim YN, Lee MJ, Seong JK, and Park JH (2009). Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse. Proteomics 9, 3824-3832.
42. Song SA, Yoo KH, Ko JY, Kim BH, Yook YJ, and Park JH (2012). Overexpression of Mxi1 represses renal epithelial tubulogenesis through the reduction of matrix metalloproteinase 9. Biochem Biophys Res Commun 419, 459-465.
43. Dugast-Darzacq C, Pirity M, Blanck JK, Scherl A, Schreiber-Agus N, Dugast- Darzacq C, Pirity M, Blanck JK, Scherl A, and Schreiber-Agus N (2004). Mxi1- SRα: a novel Mxi1 isoform with enhanced transcriptional repression potential. Oncogene 23, 8887-8899.
44. Delpuech O, Griffiths B, East P, Essafi A, Lam EW, Burgering B, Downward J, and Schulze A (2007). Induction of Mxi1-SRα by FOXO3a contributes to repression of Myc-dependent gene expression. Mol Cell Biochem 27, 4917-4930.
45. Dugast-Darzacq C, Grange T, and Schreiber-Agus NB (2007). Differential effects of Mxi1-SRα and Mxi1-SRβ inMyc antagonism. FEBS J 274, 4643-4653.
46. Boult JK, Taniere P, Hallissey MT, Campbell MJ, and Tselepis C (2008). Oesophageal adenocarcinoma is associated with a deregulation in the MYC/ MAX/MAD network. Br J Cancer 98, 1985-1992.
47. Gartel AL and Shchors K (2003). Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 283, 17-21.
48. Adhikary S and Eilers M (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6, 635-645.